Ryvu Therapeutics SA (9Y4) Stock Forecast & Price Target
9Y4 Analyst Ratings
There are no analyst ratings in the last 3 months.
9Y4 Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
No analyst ratings match these filters.
9Y4 Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, 9Y4 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 9Y4 average Analyst price target in the past 3 months is ―.
9Y4 Financial Forecast
9Y4 Earnings Forecast
Next quarter’s earnings estimate for 9Y4 is -EUR 0.13 with a range of ― to ―. The previous quarter’s EPS was -EUR 0.13. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
9Y4 Sales Forecast
Next quarter’s sales forecast for 9Y4 is EUR 4.30M with a range of EUR 4.30M to EUR 4.30M. The previous quarter’s sales results were EUR 2.71M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.